Clinical pharmacology in neonates and young infants: the benefit of a population-tailored approach.
作者信息
van den Anker John, Allegaert Karel
出版信息
Expert Rev Clin Pharmacol. 2012 Jan;5(1):5-8. doi: 10.1586/ecp.11.65.
Abstract
摘要
相似文献
1
Clinical pharmacology in neonates and young infants: the benefit of a population-tailored approach.新生儿和婴幼儿的临床药理学：个体化治疗方法的益处。
Expert Rev Clin Pharmacol. 2012 Jan;5(1):5-8. doi: 10.1586/ecp.11.65.
2
Methods in clinical pharmacology--a tale of two worlds.临床药理学方法——两个世界的故事。
Br J Clin Pharmacol. 2008 Nov;66(5):585-7. doi: 10.1111/j.1365-2125.2008.03314.x.
3
Educational paper: do we need neonatal clinical pharmacologists?教育论文：我们是否需要新生儿临床药理学家？
Eur J Pediatr. 2013 Apr;172(4):429-35. doi: 10.1007/s00431-012-1734-4. Epub 2012 May 16.
4
The clinical utility of pharmacometric models.药代动力学模型的临床应用。
Br J Clin Pharmacol. 2018 Jul;84(7):1413-1414. doi: 10.1111/bcp.13603. Epub 2018 May 2.
5
Description of controlled trials published in Methods and Findings, 1979-2002.1979年至2002年发表于《方法与发现》的对照试验描述。
Methods Find Exp Clin Pharmacol. 2006 Oct;28(8):527-31.
6
Clinical pharmacology of analgosedatives in neonates: ways to improve their safe and effective use.新生儿镇痛镇静药物的临床药理学：提高其安全有效使用的方法。
J Pharm Pharmacol. 2017 Apr;69(4):350-360. doi: 10.1111/jphp.12599. Epub 2016 Jun 30.
7
Randomized trials or population-based registries.随机试验或基于人群的登记处。
Eur J Vasc Endovasc Surg. 2007 Sep;34(3):253-6. doi: 10.1016/j.ejvs.2007.06.014.
8
Editorial: Neonatal Clinical Pharmacology: A Rapidly Maturing Discipline.社论：新生儿临床药理学：一门迅速成熟的学科。
Curr Pharm Des. 2017;23(38):5767-5768. doi: 10.2174/138161282338180209180957.
9
A systematic review of lidocaine-prilocaine cream (EMLA) in the treatment of acute pain in neonates.利多卡因-丙胺卡因乳膏（EMLA）治疗新生儿急性疼痛的系统评价。
Pediatrics. 1998 Feb;101(2):E1. doi: 10.1542/peds.101.2.e1.
10
Benefit and risk assessment in drug development and utilization: a role for clinical pharmacology.药物研发与应用中的获益和风险评估：临床药理学的作用
Clin Pharmacol Ther. 2007 Aug;82(2):109-12. doi: 10.1038/sj.clpt.6100277.
引用本文的文献
1
USE OF OFF-LABEL MEDICATIONS IN A NEONATAL INTENSIVE CARE UNIT.在新生儿重症监护病房中使用超说明书用药。
Rev Paul Pediatr. 2021 Jan 11;39:e2020063. doi: 10.1590/1984-0462/2021/39/2020063. eCollection 2021.
2
Gender Differences in Outpatient Pediatric Drug Utilization: A Cohort Study From Southern Italy.意大利南部一项队列研究：儿科门诊用药的性别差异
Front Pharmacol. 2019 Feb 5;10:11. doi: 10.3389/fphar.2019.00011. eCollection 2019.
3
Physiologically Based Pharmacokinetic Prediction of Linezolid and Emtricitabine in Neonates and Infants.基于生理学的利奈唑胺和恩曲他滨在新生儿和婴儿体内的药代动力学预测
Clin Pharmacokinet. 2017 Apr;56(4):383-394. doi: 10.1007/s40262-016-0445-9.
4
Neuroprotective Strategies after Neonatal Hypoxic Ischemic Encephalopathy.新生儿缺氧缺血性脑病后的神经保护策略
Int J Mol Sci. 2015 Sep 15;16(9):22368-401. doi: 10.3390/ijms160922368.
5
Rapid detection of chloramphenicol residues in aquatic products using colloidal gold immunochromatographic assay.采用胶体金免疫层析法快速检测水产品中氯霉素残留量
Sensors (Basel). 2014 Nov 18;14(11):21872-88. doi: 10.3390/s141121872.
6
Neonates need tailored drug formulations.新生儿需要量身定制的药物制剂。
World J Clin Pediatr. 2013 Feb 8;2(1):1-5. doi: 10.5409/wjcp.v2.i1.1.
7
Clinical pharmacological studies in children: From exploratory towards confirmation driven methodology.儿童临床药理学研究：从探索性方法向验证驱动型方法的转变
World J Clin Pediatr. 2012 Aug 8;1(2):3-7. doi: 10.5409/wjcp.v1.i2.3.
8
Current management of late onset neonatal bacterial sepsis in five European countries.欧洲五个国家晚期新生儿细菌性败血症的当前管理
Eur J Pediatr. 2014 Aug;173(8):997-1004. doi: 10.1007/s00431-014-2279-5. Epub 2014 Feb 13.
9
How to optimize the evaluation and use of antibiotics in neonates.如何优化新生儿抗生素的评估和使用。
Pediatr Clin North Am. 2012 Oct;59(5):1117-28. doi: 10.1016/j.pcl.2012.07.004. Epub 2012 Sep 1.
本文引用的文献
1
Developmental pharmacokinetics.发育药代动力学
Handb Exp Pharmacol. 2011;205:51-75. doi: 10.1007/978-3-642-20195-0_2.
2
Creatinaemia at birth is equal to maternal creatinaemia at delivery: does this paradigm still hold?出生时的血肌酐水平与分娩时母亲的血肌酐水平相等：这一范例是否仍然成立？
J Matern Fetal Neonatal Med. 2012 Jul;25(7):978-80. doi: 10.3109/14767058.2011.602144. Epub 2011 Aug 25.
3
Neonatal nephrology and laboratory medicine: an effective interdisciplinary model to improve the outcome in neonatal intensive care unit.
J Matern Fetal Neonatal Med. 2011 Oct;24 Suppl 2:1-2. doi: 10.3109/14767058.2011.606627.
4
Postnatal trends in creatinemia and its covariates in extremely low birth weight (ELBW) neonates.极低出生体重（ELBW）新生儿肌酸酐及其协变量的产后变化趋势。
Pediatr Nephrol. 2011 Oct;26(10):1843-9. doi: 10.1007/s00467-011-1883-0. Epub 2011 Apr 17.
5
Cytostatic drugs in infants: a review on pharmacokinetic data in infants.婴儿期的细胞毒性药物：婴儿药代动力学数据综述。
Cancer Treat Rev. 2012 Feb;38(1):3-26. doi: 10.1016/j.ctrv.2011.03.005. Epub 2011 Apr 13.
6
Inattentive behaviour is associated with poor working memory and slow processing speed in very pre-term children in middle childhood.在儿童中期，注意力不集中的行为与非常早产儿的工作记忆差和处理速度慢有关。
Br J Educ Psychol. 2011 Mar;81(Pt 1):147-60. doi: 10.1348/000709910X505527.
7
Drug policy in Europe Research and funding in neonates: current challenges, future perspectives, new opportunities.欧洲的毒品政策：新生儿研究与资金投入——当前的挑战、未来的展望、新的机遇。
Early Hum Dev. 2011 Mar;87 Suppl 1:S27-30. doi: 10.1016/j.earlhumdev.2011.01.007. Epub 2011 Jan 26.
8
Beyond biomarkers: an opportunity to address the 'pharmacodynamic gap' in pediatric drug development.超越生物标志物：解决儿科药物开发中“药效学差距”的契机。
Biomark Med. 2010 Dec;4(6):783-6. doi: 10.2217/bmm.10.106.
9
The role of population PK-PD modelling in paediatric clinical research.群体 PK-PD 模型在儿科临床研究中的作用。
Eur J Clin Pharmacol. 2011 May;67 Suppl 1(Suppl 1):5-16. doi: 10.1007/s00228-009-0782-9. Epub 2010 Mar 26.
10
Challenges in conducting clinical trials in children: approaches for improving performance.儿童临床试验面临的挑战：提高试验绩效的方法。
Expert Rev Clin Pharmacol. 2009 Nov 1;2(6):609-617. doi: 10.1586/ecp.09.40.
Zotero 插件